Search clinical trials for: Fentanyl Sublingual Spray (FSS)

Total 39 results

INSYS Therapeutics Inc

Withdrawn

Fentanyl Sublingual Spray for the Treatment of Acute Procedure-related Pain in a Monitored Setting

Chronic Pain
INSYS Therapeutics Inc

Withdrawn

Study to Explore Effectiveness of Sublingual Fentanyl Spray in Emergency Department Patients With Acute Pain

Acute Pain

United States
M.D. Anderson Cancer Center
INSYS Therapeutics Inc

Terminated

Sublingual Fentanyl for the Management of Breakthrough Pain

Advanced Cancers

United States
M.D. Anderson Cancer Center
INSYS Therapeutics Inc

Completed

Fentanyl Sublingual Spray for Exercise-Induced Breakthrough Dyspnea

Advanced Cancers

United States
NPO Petrovax

Completed

Efficacy and Safety of Polyoxidonium, Nasal and Sublingual Spray, 6 mg/ml in Children Aged 1-12 Years With ARI

Acute Respiratory Infection

Russian Federation
INSYS Therapeutics Inc

Completed

Exploratory Bioavailability of Fentanyl Sublingual Spray Under Fasting Conditions

Bioavailability

United States
INSYS Therapeutics Inc

Completed

Long-term Safety and Efficacy Study of Fentanyl Sublingual Spray for the Treatment of Breakthrough Cancer Pain

Pain | Cancer

United States, India, Canada
Loyola University

Terminated

Sublingual Fentanyl and Procedural Burn Pain

Burn Pain

United States
INSYS Therapeutics Inc

Completed

Fentanyl Sublingual Spray in Treating Opioid-tolerant Cancer Patients With or Without Oral Mucositis

Pain | Unspecified Adult Solid Tumor, Protocol Specific | Mucositis

United States
INSYS Therapeutics Inc

Completed

Fentanyl Sublingual Spray in Opioid Naive Participants

Pharmacology

United States
INSYS Therapeutics Inc
National Cancer Institute (NCI)

Completed

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Cancer

United States
Azienda Sanitaria dell'Alto Adige
Institute of Mountain Emergency Medicine

Completed

Sublingual Versus Endovenous Fentanyl for the Prehospital Analgesia in Patients With Limb Trauma on the Slope

Acute Pain Due to Trauma

Italy
Azienda Sanitaria dell'Alto Adige

Completed

Sublingual Versus Endovenous Fentanyl for Pain Treatment in Trauma Patients in the Emergency Room

Acute Pain Due to Trauma

Italy
Simon Fraser University
University of British Columbia

Not yet recruiting

NO AD: Use of Nitric Oxide (NO) Donors for the Prevention of Autonomic Dysreflexia (AD) During Bowel Care Following SCI (NO AD)

Spinal Cord Injuries | Autonomic Dysreflexia
INSYS Therapeutics Inc

Completed

Study of Buprenorphine-Naloxone Sublingual Spray and Suboxone® Sublingual Film in Healthy Volunteers

Opiate Dependence

United States
M.D. Anderson Cancer Center
Depomed

Completed

Fentanyl Pectin Nasal Spray (FNPS) for Exercise-Induced Breakthrough Dyspnea

Advanced Cancers

United States
M.D. Anderson Cancer Center
Archimedes Pharma US, Inc.

Terminated

Fentanyl for Breakthrough Pain in the Emergency Department

Pain

United States
INSYS Therapeutics Inc

Completed

Pharmacokinetic Study of Fentanyl 400 µg Sublingual Spray, Actiq® 400 µg Transmucosally, and Fentanyl Citrate Injection 100 µg Intravenously (iv)

Pain

United States
Aziende Chimiche Riunite Angelini Francesco S.p.A
Zak-Pharma Dienstleistung Ges.m.b.H.

Completed

Benzydamine in Sore Throat Pain Relief (BePaiR Study) (BePaiR)

Acute Sore Throat

Hungary, Poland, Russian Federation
University of Minnesota

Completed

Sublingual Sufentanil vs Intravenous Fentanyl for Acute Pain in the Ambulatory Surgery Center

Pain | Pain, Acute | Anesthesia

United States
Archimedes Development Ltd

Completed

Efficacy & Safety Study of Nasalfent (Fentanyl Citrate Nasal Spray) for Treatment of Breakthrough Cancer Pain in Patients Taking Regular Opioids

Cancer Pain

United States
University of Texas at Austin

Not yet recruiting

Intranasal Fentanyl in Combination With Midazolam Versus Midazolam Alone for Pediatric Facial Laceration Repair

Anxiety | Facial Laceration
Archimedes Development Ltd

Completed

Long Term Safety Study of Nasalfent (Fentanyl Citrate Nasal Spray) for Treatment of Breakthrough Cancer Pain

Cancers, Pain
INSYS Therapeutics Inc

Terminated

Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain

Post-operative Pain

United States
Prince of Songkla University

Completed

The Effect of Intravenous Fentanyl Prior the End of Surgery on Emergence Agitation in Paediatric Patients After General Anesthesia

Agitation

Thailand
Archimedes Development Ltd

Unknown

Patient Satisfaction and Quality of Life Impact - PecFent® (Qualipec)

Breakthrough Cancer Pain

Spain
Archimedes Development Ltd

Unknown

Patient Satisfaction and Quality of Life Impact - PecFent® (Qualipec)

Breakthrough Cancer Pain

France
Takeda

Completed

A Trial to Investigate the Pharmacokinetics (PK) of Single Doses of 200 µg, 400 µg and 2 x 400 µg of Intranasal Fentanyl Spray (INFS) in Healthy Subjects (PK400 INFS)

Healthy Volunteers

Germany
Takeda

Completed

A Clinical Trial With Intranasal Fentanyl in Cancer Patients With Breakthrough Pain (NOSE-400)

Cancer | Break Through Pain

Russian Federation, Hungary, Norway
McGill University

Unknown

Effect of Sublingual Fentanyl on Breathlessness in COPD

Copd
M.D. Anderson Cancer Center

Completed

Compare Fentanyl Nasal Spray With Intravenous Opioids to Treat Severe Pain

Pain | Advanced Cancers

United States
University of Louisville
James Graham Brown Cancer Center

Withdrawn

An Assessment of the Ability of Fentanyl Citrate Nasal Spray to Manage Breakthrough Pain in Cancer Patients. (FCNS)

Pain

United States
Norwegian University of Science and Technology
Maastricht University Medical Center; Fondazione IRCCS Istituto Nazionale dei... and other collaborators

Withdrawn

Nasal Fentanyl for Chronic Cancer Pain (NFCP-2)

Pain | Cancer
Proto Pharma Ltd

Completed

Superiority of ArTiMist Versus Quinine in Children With Severe Malaria

Plasmodium Falciparum Malaria

Burkina Faso, Ghana, Rwanda
L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio...
Consorzio Mario Negri Sud

Withdrawn

PEctin Rapid Fentanyl Efficacy Clinical Trial For pAin at Swallowing Undergoing radioTherapy (PERFECT FAST)

Predictable BTP at Swallowing in in Head/Neck Cancer Patients Undergoing Radiotherapy Already Receiving Opioid Therapy for Background Pain

Italy
INSYS Therapeutics Inc

Completed

Study of Buprenorphine Sublingual Spray Versus Standard of Care Narcotic Therapy for the Treatment of Post-Operative Pain

Pain, Postoperative

United States
Dr. Sami Ulus Children's Hospital

Completed

Comparison of Sublingual Misoprostol Versus Lidocaine Spray for Hysteroscopy

Pain During Hysteroscopy

Turkey
Medical University of Warsaw

Completed

Cardiac Arrhythmias in Patients Undergoing Kidney Cancer Surgery Depending on the Anaesthesia Method

Kidney Cancer | Anesthesia, Local | Surgery | Arrhythmia, Cardiac

Poland
Universidade Gama Filho
Instituto Nacional de Cardiologia de Laranjeiras

Completed

Renin-angiotensin-aldosterone System Polymorphisms in Resistant Hypertension and Adverse Cardiovascular Events (GENHART)

Myocardial Infarction | Stroke | Hypertension Resistant to Conventional Therapy | Systemic Arterial Hypertension

Brazil

3

Subscribe